# OnCo record checkmate-743 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/checkmate-743/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "checkmate-743", "NCT02899299" ;
  schema:name "CheckMate 743"@en ;
  schema:description "CheckMate 743 was the first immunotherapy trial to lengthen survival in mesothelioma, and gave the first new first-line option in 16 years."@en ;
  schema:url <https://onco.cc/trials/checkmate-743/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02899299> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2016-11-29" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/pleural-mesothelioma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/pemetrexed/> ;
  onco:terms <https://onco.cc/terms/epithelioid-vs-sarcomatoid/> ;
  onco:people <https://onco.cc/people/paul-baas/>, <https://onco.cc/people/solange-peters/> .